Core Viewpoint - The company has disclosed its quarterly report, ensuring the accuracy and completeness of financial information, and has undertaken legal responsibilities for any misrepresentation or omissions [2][3]. Financial Data - The company has not restated or adjusted previous accounting data and confirms that non-recurring gains and losses are applicable, specifically mentioning the refund of personal income tax handling fees as a non-recurring item [3][4]. - As of February 5, 2025, the company has repurchased a total of 1,028,148 shares, accounting for 0.95% of the total share capital, with a total transaction amount of approximately 41.99 million yuan [6]. Shareholder Information - The company has not reported any changes in the top ten shareholders or the status of shares lent out for margin trading [5]. Other Important Matters - The company has established a wholly-owned subsidiary in Germany, "Highfine Biotech GmbH," with a registered capital of 200,000 euros, aimed at enhancing its competitive edge and expanding its market presence in Europe [7]. - The company’s production capacity is being expanded, with the first phase of its Anhui production base having commenced operations in August 2022, and a new project expected to obtain production licenses by January 2025 [9].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002425 证券简称：ST凯文 公告编号：2025-031 凯撒（中国）文化股份有限公司2025年第一季度报告 证券代码：002425 证券简称：ST凯文 公告编号：2025-031 凯撒（中国）文化股份有限公司 2025年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经审计 □是 √否 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 ■ （二） 非经常性损益项目和金额 √适用 □不适用 单位：元 ■ 其他符合非经常性损益定义的损益项目的具体情况 □适用 √不适用 公司不存在将《公开发行证券的公司信息披露解释性公告第1号一一非经常性损 ...

| 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0418 | -0.0798 | 152.38 | -0.0744 | | 每股净资产（元） | 0.47 | 0.23 | 104.35 | -0.19 | | 每股公积金(元) | 1.34 | 1.34 | 0 | 0.6 | | 每股未分配利润(元) | -2.06 | -2.31 | 10.82 | -1.99 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 0.52 | 0.28 | 85.71 | 0.22 | | 净利润(亿元) | 0.05 | -0.1 | 150 | -0.09 | | 净资产收益率(%) | 9.27 | -30.12 | 130.78 | | 数据四舍五入，查看更多财务数据>> 一、主要会计数据和财务指标 三、分红送配方案情况 本次公司不分配不转赠。 | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况( ...

Financial Performance - The company reported a basic earnings per share of 0.9500 yuan for 2024, an increase of 10.47% compared to 0.8600 yuan in 2023 [1] - The total revenue for 2024 was 9.87 billion yuan, reflecting a growth of 15.57% from 8.54 billion yuan in 2023 [1] - The net profit for 2024 reached 0.66 billion yuan, up 11.86% from 0.59 billion yuan in the previous year [1] - The return on equity (ROE) improved to 9.07% in 2024, a significant increase of 28.47% from 7.06% in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 5.109 million shares, accounting for 16.94% of the circulating shares, which is a decrease of 267.55 thousand shares from the previous period [1] - Notable changes among the top shareholders include a significant reduction in holdings by Wang Zhenhuai, who decreased his shares by 39.98% to 156.00 thousand shares [2] - New entrants to the top ten shareholders include Ren Lixia, Beijing Tongfeng Private Fund Management Co., Ltd., and Xiao Shiqiang, each holding 22.20 thousand, 17.87 thousand, and 15.05 thousand shares respectively [2] Dividend Distribution - The company announced a dividend distribution plan of 10 shares for every 4.5 shares held, along with a cash dividend of 3.5 yuan (including tax) [3]

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.2300 | -0.2700 | 14.81 | -0.2200 | | 每股净资产（元） | 3.07 | 3.43 | -10.5 | 3.68 | | 每股公积金(元) | 0.68 | 0.69 | -1.45 | 0.68 | | 每股未分配利润(元) | 1.29 | 1.52 | -15.13 | 1.79 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 6.22 | 6.16 | 0.97 | 15 | | 净利润(亿元) | -0.85 | -1 | 15 | -0.83 | | 净资产收益率(%) | -7.02 | -7.56 | 7.14 | -5.82 | 三、分红送配方案情况 不分配不转增 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 13846.57万股，累计占流通股比： 42.48%，较上期 ...

一、主要会计数据和财务指标 前十大流通股东累计持有： 9123.96万股，累计占流通股比： 27.37%，较上期变化： -153.95万股。 | 名称 | 持有数量(万股) | 占总股本比例(%) | 增减情况(万股) | | --- | --- | --- | --- | | 李昭强 | 2879.87 | 8.64 | 不变 | | 纪法清 | 2445.44 | 7.34 | 不变 | | 宋叶 | 1867.13 | 5.60 | -148.03 | | 辛军 | 474.80 | 1.42 | 不变 | | 王少成 | 310.34 | 0.93 | 不变 | | 贾启超 | 302.67 | 0.91 | 不变 | | 张义 | 267.24 | 0.80 | -65.00 | | 刘雪英 | 215.79 | 0.65 | 不变 | | 隋启海 | 180.38 | 0.54 | 新进 | | 陆丽红 | 180.30 | 0.54 | 新进 | | | 较上个报告期退出前十大股东有 | | | | 蔡勇 | 170.00 | 0.51 | 退出 | | 张杰 | 131.60 | 0.40 | ...

Financial Data and Indicators - The basic earnings per share for Q1 2025 is 0.2700 CNY, representing a 12.5% increase compared to Q1 2024, which was 0.2400 CNY [1] - The net profit for Q1 2025 is 0.26 billion CNY, showing a 13.04% increase from Q1 2024's 0.23 billion CNY [1] - The return on equity for Q1 2025 is 1.41%, up 7.63% from 1.31% in Q1 2024 [1] - The total operating revenue for Q1 2025 is 1.73 billion CNY, a decrease of 2.26% from 1.77 billion CNY in Q1 2024 [1] Shareholder Information - The top ten unrestricted shareholders hold a total of 32.574 million shares, accounting for 57.02% of the circulating shares, with a decrease of 3.1175 million shares compared to the previous period [2] - Ningbo Kangyunfu Equity Investment Co., Ltd. holds 11.52 million shares, representing 20.16% of the total share capital, with no change [2] - The E Fund Healthcare Industry Mixed A fund has reduced its holdings by 549,400 shares, now holding 3.7355 million shares, which is 6.54% of the total [2] Dividend Distribution - The company will not distribute or transfer any dividends this time [3]

数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 一、主要会计数据和财务指标 前十大流通股东累计持有： 48983.53万股，累计占流通股比： 57.57%，较上期变化： -102.05万股。 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0013 | 0.0114 | -88.6 | 0.0007 | | 每股净资产（元） | 0.94 | 0.84 | 11.9 | 0.79 | | 每股公积金(元) | 3.06 | 3.04 | 0.66 | 3.04 | | 每股未分配利润(元) | -3.10 | -3.17 | 2.21 | -3.26 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 2.13 | 3.12 | -31.73 | 2.11 | | 净利润(亿元) | 0.01 | 0.1 | -90 | 0.01 | | 净资产收益率(%) | 0.13 | 1.36 | ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.0120 | 0.0010 | 1100 | -0.0200 | | 每股净资产（元） | 7.07 | 7.09 | -0.28 | 7.17 | | 每股公积金(元) | 3.43 | 3.48 | -1.44 | 3.53 | | 每股未分配利润(元) | 2.38 | 2.32 | 2.59 | 2.36 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.05 | 0.95 | 10.53 | 0.94 | | 净利润(亿元) | 0.02 | 0 | 0 | -0.03 | | 净资产收益率(%) | 0.16 | 0.02 | 700 | -0.32 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 8800.6万股，累计占流通股比： 47.99%，较上期变化： 638 ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0924 | -0.1376 | 32.85 | -0.1722 | | 每股净资产（元） | 3.8 | 4.38 | -13.24 | 5.13 | | 每股公积金(元) | 3.47 | 3.61 | -3.88 | 3.61 | | 每股未分配利润(元) | -0.67 | -0.12 | -458.33 | 0.65 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 3.48 | 3.23 | 7.74 | 2.95 | | 净利润(亿元) | -0.24 | -0.36 | 33.33 | -0.45 | | 净资产收益率(%) | -1.98 | -3.03 | 34.65 | -2.63 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 4513.12万股，累计占流通 ...